Projects per year
Search results
-
Not started
Phase III_Parsaclisib and Ruxolitinib_Myelofibrosis_INCB 50465-313 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Combination of PI3K Inhibitor Parsaclisib and Ruxolitinib in Participants With Myelofibrosis
Shah, S., Darcourt, J., Petkova, J., Pingali, S. R. & Rice, L.
Project: Clinical Trial